Aspirin resistance in diabetic patients

被引：5

作者：

De Gaetano, G ^{[1
]}

机构：

[1] Catholic Univ, Res Labs, Ctr High Technol Res & Educ Biomed Sci, I-86100 Campobasso, Italy

来源：

DIABETES CARE | 2004年 / 27卷 / 05期

关键词：

D O I：

10.2337/diacare.27.5.1244-a

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1244 / 1245

页数：2

共 9 条

[1] Aspirin resistance: a revival of platelet aggregation tests? [J].

De Gaetano, G ;

Cerletti, C .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (09) :2048-2050

[2]

de Gaetano G, 2001, Ital Heart J, V2, P582

[3] Platelet responsiveness to aspirin in patients with hyperlipidaemia [J].

Friend, M ;

Vucenik, I ;

Miller, M .

BRITISH MEDICAL JOURNAL, 2003, 326 (7380) :82-83

[4]

*HLTH STUD RES GRO, 1989, NEW ENGL J MED, V3221, P129

[5] Determination of who may derive most benefit from aspirin in primary prevention: subgroup results from a randomised controlled trial [J].

Meade, TW ;

Brennan, PJ .

BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7252) :13-17

[6] Aspirin resistance: definition, mechanisms and clinical read-outs [J].

Patrono, C .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (08) :1710-1713

[7]

*PPP, 2001, LANCET, V357, P1134

[8] Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: Results of the Primary Prevention Project (PPP) trial [J].

Sacco, M ;

Pellegrini, F ;

Roncaglioni, MC ;

Avanzini, F ;

Tognoni, G ;

Nicolucci, A .

DIABETES CARE, 2003, 26 (12) :3264-3272

[9]

Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X

← 1 →